Document 0848
 DOCN  M9540848
 TI    Optimization of a fed-batch process for production of a recombinant
       antibody.
 DT    9504
 AU    Robinson DK; Seamans TC; Gould SL; DiStefano DJ; Chan CP; Lee DK; Bibila
       T; Glazomitsky K; Munshi S; Daugherty B; et al; Merck Research
       Laboratories, Rahway, New Jersey 07065.
 SO    Ann N Y Acad Sci. 1994 Nov 30;745:285-96. Unique Identifier : AIDSLINE
       MED/95133942
 DE    Amino Acids/ANALYSIS  Animal  Antibodies,
       Monoclonal/*BIOSYNTHESIS/GENETICS  Cytomegalovirus/GENETICS  DNA,
       Complementary/GENETICS  Gene Expression Regulation/DRUG EFFECTS  Genes,
       Reporter  Genes, Synthetic  Genetic Vectors  Glutamate-Ammonia
       Ligase/BIOSYNTHESIS/GENETICS  Human  HIV
       Antibodies/*BIOSYNTHESIS/GENETICS  HIV Envelope Protein
       gp120/*IMMUNOLOGY  Immunoglobulins, Heavy-Chain/*BIOSYNTHESIS/GENETICS
       Immunoglobulins, Light-Chain/*BIOSYNTHESIS/GENETICS  Mice
       Plasmacytoma/PATHOLOGY  Promoter Regions (Genetics)  Recombinant Fusion
       Proteins/*BIOSYNTHESIS/GENETICS  Tissue Culture/*METHODS  Tumor Cells,
       Cultured  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).